insights_auto
Why is AGIO down ३.१०%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २८.७६
arrow_downward
-३.१०%(-०.९२) 1D
US$ २८.७६
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १९, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.९३
High
US$ ३०.३५
Low
US$ २८.७१
Mkt. cap
१.७२ अरब
Avg. vol.
११.७७ लाख
Volume
०.००
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.९३
High
US$ ३०.३५
Low
US$ २८.७१
Mkt. cap
१.७२ अरब
Avg. vol.
११.७७ लाख
Volume
०.००
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Benzinga
·
१ घण्टा पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
१ घण्टा पहिले
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
Adam Feldman | Substack
·
१३ घण्टा पहिले
Inside the Federal Litigation of Five S&P 500 Giants
BigGo Finance
·
६ घण्टा पहिले
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc